Association of Hashimoto's thyroiditis with thyroid cancer

Endocrine-Related Cancer

Volumn 21, Issue 6, 2014, Pages 845-852

  Azizi, G ^a   Keller, J M ^b   Lewis, M ^a   Piper, K ^c   Puett, D ^d   Rivenbark, K M ^a   Malchoff, C D ^e  

^a ECNU Wilmington Endocrinology   (United States)

^b Wilmington Health Associates   (United States)

^c CHILDREN S HOSPITAL COLORADO   (United States)

^d Carolina Arthritis Associates   (United States)

^e UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

FNAB; Hashimoto's thyroiditis; TgAb; Thyroid cancer; Thyroid nodule

Indexed keywords

ANTI-THYROGLOBULIN; AUTOANTIBODY; THYROGLOBULIN; THYROXINE;

BLOOD; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HASHIMOTO DISEASE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY;

AUTOANTIBODIES; BIOPSY, FINE-NEEDLE; FEMALE; FOLLOW-UP STUDIES; HASHIMOTO DISEASE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; THYROGLOBULIN; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; THYROXINE;

EID: 84919636229     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-14-0258     Document Type: Article

References (35)

1. Anil C, Goksel S & Gursoy A 2010 Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid 20 601-606. (doi:10.1089/thy.2009.0450)
2. Azizi G & Malchoff CD 2011 Autoimmune thyroid disease: a risk factor for thyroid cancer. Endocrine Practice 17 201-209. (doi:10.4158/EP10123.OR)
3. Boelaert K 2009 The association between serum TSH concentration and thyroid cancer. Endocrine-Related Cancer 16 1065-1072. (doi:10.1677/ERC-09-0150)
4. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC & Franklyn JA 2006 Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. Journal of Clinical Endocrinology and Metabolism 91 4295-4301. (doi:10.1210/jc.2006-0527)
5. Bradly D, Reddy V, Prinz RA & Gattuso P 2009 Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery 146 1099-1104. (doi:10.1016/j.surg.2009.09.025)
6. Carson H, Castelli M & Gattuso P 1996 Incidence of neoplasia in Hashimoto's thyroiditis: a fine-needle aspiration study. Diagnostic Cytopathology 14 38-42. (doi:10.1002/(SICI)1097-0339(199602) 14:1!38::AID-DC8O3.0.CO;2-R)
7. Cibas ES & Ali SZ 2009 The Bethesda system for reporting thyroid cytopathology. American Journal of Clinical Pathology 132 658-665. (doi:10.1309/AJCPPHLWMI3JV4LA)
8. Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, Latteri S & Latteri MA 2005 Hashimoto's thyroiditis coexistent with papillary thyroid carcinoma. American Surgeon 71 874-878.
9. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M et al. 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19 1167-1214. (doi:10.1089/thy.2009.0110)
10. Crile GJ & Hazard JB 1962 Incidence of cancer in struma lymphomatosa. Surgery, Gynecology & Obstetrics 115 101-103.
11. Cunha LL, Ferreira RC, Marcello MA, Vassallo J & Ward LS 2011 Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer. Journal of Thyroid Research 2011 387062. (doi:10.4061/2011/387062)
12. Dailey ME, Lindsay S & Skahen R 1955 Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. A.M.A. Archives of Surgery 70 291-297. (doi:10.1001/archsurg.1955.01270080137023)
13. Erdogan M, Erdem N, Cetinkalp S, Ozgen AG, Saygili F, Yilmaz C, Tuzun M & Kabalak T 2009 Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto's thyroiditis: results of a university hospital of 769 patients in Turkey. Endocrine 36 486-490. (doi:10.1007/s12020-009-9258-z)
14. Guarino V, Castellone MD, Avilla E & Melillo RM 2010 Thyroid cancer and inflammation. Molecular and Cellular Endocrinology 321 94-102. (doi:10.1016/j.mce.2009.10.003)
15. Gul K, Ozdemir D, Dirikoc A, Oguz A, Tuzun D, Baser H, Ersoy R & Cakir B 2010 Are endogenously lower serum thyroid hormones new predictors for thyroid malignancy in addition to higher serum thyrotropin? Endocrine 37 253-260. (doi:10.1007/s12020-010-9316-6)
16. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC & Chen H 2008 Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. Journal of Clinical Endocrinology and Metabolism 93 809-814. (doi:10.1210/jc.2007-2215)
17. HaymartMR, Glinberg SL, Liu J, Sippel RS, Jaume JC & Chen H 2009 Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clinical Endocrinology 71 434-439. (doi:10.1111/j.1365-2265.2008.03489.x)
18. Holm LE, Blomgren H & Lowhagen T 1985 Cancer risks in patients with chronic lymphocytic thyroiditis. New England Journal of Medicine 312 601-604. (doi:10.1056/NEJM198503073121001)
19. Jankovic B, Le KT & Hershman JM 2013 Clinical Review: Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation? Journal of Clinical Endocrinology and Metabolism 98 474-482. (doi:10.1210/jc.2012-2978)
20. Jin J, Machekano R & McHenry CR 2010 The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease. American Journal of Surgery 199 294-297. (doi:10.1016/j.amjsurg.2009.08.028)
21. Joseph CG, Darrah E, Shah AA, Skora AD, Casciola-Rosen LA, Wigley FM, Boin F, Fava A, Thoburn C, Kinde I et al. 2014 Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science 343 152-157. (doi:10.1126/science.1246886)
22. Kim ES, Lim DJ, Baek KH, Lee JM, Kim MK, Kwon HS, Song KH, Kang MI, Cha BY, Lee KW et al. 2010 Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid 20 885-891. (doi:10.1089/thy.2009.0384)
23. Kurukahvecioglu O, Taneri F, Yuksel O, Aydin A, Tezel E & Onuk E 2007 Total thyroidectomy for treatment of Hashimoto's thyroiditis coexisting with papillary thyroid carcinoma. Advances in Therapy 24 510-516. (doi:10.1007/BF02848773)
24. Larson SD, Jackson LN, Riall TS, Uchida T, Thomas RP, Qiu S & Evers BM 2007 Increased incidence of well-differentiated thyroid cancer associated with Hashimoto's thyroiditis and the role of the PI3k/Akt pathway. Journal of the American College of Surgeons 204 764-773 discussion 773-5. (doi:10.1016/j.jamcollsurg.2006.12.037)
25. Latrofa F, Ricci D, Montanelli L, Rocchi R, Piaggi P, Sisti E, Grasso L, Basolo F, Ugolini C, Pinchera A et al. 2012 Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin. Journal of Clinical Endocrinology and Metabolism 97 2380-2387. (doi:10.1210/jc.2011-2812)
26. Matesa-Anić D, Matesa N, Dabelić N & Kusić Z 2009 Coexistence of papillary carcinoma and Hashimoto's thyroiditis. Acta Clinica Croatica 48 9-12.
27. Mazokopakis EE, Tzortzinis AA, Dalieraki-Ott EI, Tsartsalis AN, Syros PK, Karefilakis CM, Papadomanolaki MG & Starakis IK 2010 Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study. Hormones 9 312-317. (doi:10.14310/horm.2002.1282)
28. McLeod DS, Watters KF, Carpenter AD, Ladenson PW, Cooper DS & Ding EL 2012 Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. Journal of Clinical Endocrinology and Metabolism 97 2682-2692. (doi:10.1210/jc.2012-1083)
29. Mukasa K, Noh JY, Kunii Y, MatsumotoM, Sato S, Yasuda S, Suzuki M, Ito K & Ito K 2011 Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases. Thyroid 21 37-41. (doi:10.1089/thy.2010.0050)
30. Ott RA, Calandra DB, McCall A, Shah KH, Lawrence AM & Paloyan E 1985 The incidence of thyroid carcinoma in patients with Hashimoto's thyroiditis and solitary cold nodules. Surgery 98 1202-1206.
31. Repplinger D, Bargren A, Zhang YW, Adler JT, HaymartM& Chen H 2008 Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer. Journal of Surgical Research 150 49-52. (doi:10.1016/j.jss.2007.09.020)
32. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A & Shah JP 1999 Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact of presentation, management and outcome. Surgery 126 1070-1077. (doi:10.1067/msy.2099.101431)
33. Siriweera EH & Ratnatung NV 2010 Profile of Hashimoto's thyroiditis in Sri Lankans: is there an increased risk of ancillary pathologies in Hashimoto's thyroiditis. Journal of Thyroid Research 2010 1-5. (doi:10.4061/2010/124264)
34. Spencer CA 2011 Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). Journal of Clinical Endocrinology and Metabolism 96 3615-3627. (doi:10.1210/jc.2011-1740)
35. Spencer C, Petrovic I & Fatemi S 2011 Current thyroglobulin auto antibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism 96 1283-1291. (doi:10.1210/jc.2010-2762)